These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 6766186

  • 1. Chronic haloperidol or fluphenazine: effects on dopamine metabolism in brain, cerebrospinal fluid and plasma of Cercopithecus aethiops (vervet monkey).
    Bacopoulos NG, Redmond DE, Baulu J, Roth RH.
    J Pharmacol Exp Ther; 1980 Jan; 212(1):1-5. PubMed ID: 6766186
    [Abstract] [Full Text] [Related]

  • 2. Chronic treatment with haloperidol or fluphenazine decanoate: regional effects on dopamine and serotonin metabolism in primate brain.
    Bacopoulos NG, Bustos G, Redmond DE, Roth RH.
    J Pharmacol Exp Ther; 1982 Apr; 221(1):22-8. PubMed ID: 6174729
    [No Abstract] [Full Text] [Related]

  • 3. Dopamine turnover in the intact rabbit brain: effect of pentobarbital or haloperidol.
    Barkai AI.
    J Pharmacol Exp Ther; 1978 Apr; 205(1):133-40. PubMed ID: 633078
    [Abstract] [Full Text] [Related]

  • 4. Antipsychotic drugs: differential effects on dopamine neurons in basal ganglia and mesocortex following chronic administration in human and nonhuman primates.
    Roth RH, Bacopoulos NG, Bustos G, Redmond DE.
    Adv Biochem Psychopharmacol; 1980 Apr; 24():513-20. PubMed ID: 6105797
    [No Abstract] [Full Text] [Related]

  • 5. Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
    Haleem DJ, Batool F, Khan NH, Kamil N, Ali O, Saify ZS, Haleem MA.
    Med Sci Monit; 2002 Sep; 8(9):BR354-61. PubMed ID: 12218936
    [Abstract] [Full Text] [Related]

  • 6. Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment.
    Wheeler SC, Roth RH.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):151-9. PubMed ID: 7190650
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serotonin and dopamine metabolites in brain regions and cerebrospinal fluid of a primate species: effects of ketamine and fluphenazine.
    Bacopoulos NG, Redmond DE, Roth RH.
    J Neurochem; 1979 Apr; 32(4):1215-8. PubMed ID: 107277
    [No Abstract] [Full Text] [Related]

  • 9. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK, Hubbard JW, Marder SR, Marshall BD, Van Putten T.
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [Abstract] [Full Text] [Related]

  • 10. [Homovanillic acid content in the cerebrospinal fluid as an index of dopamine cerebral metabolism before and after a stereotaxic operation in patients with extrapyramidal hyperkinetic syndromes].
    Barkhatova VP, Kandel' EI, Omorova TM, Demina EG.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984 Jul; 84(7):1050-5. PubMed ID: 6382885
    [Abstract] [Full Text] [Related]

  • 11. A central 6-hydroxydopamine lesion prevents fluphenazine-induced increase in plasma homovanillic acid.
    Labarca R, Thomas JW, Koulu M, Kim YS, Janowsky A, Wilkinson L, Linnoila M, Paul SM, Pickar D.
    Brain Res Bull; 1988 May; 20(5):567-71. PubMed ID: 3133084
    [Abstract] [Full Text] [Related]

  • 12. [Approaches to the study of dopamine metabolism in various extrapyramidal diseases].
    Barkhatova VP, Kandel' EI, Demina EG.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981 May; 81(7):1021-9. PubMed ID: 6457476
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Brain homovanillic acid: regional changes following chronic antipsychotic drug administration.
    Bowers MB, Rozitis A.
    Adv Biochem Psychopharmacol; 1977 May; 16():639-44. PubMed ID: 18907
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Behavioral and biochemical correlates after haloperidol and clozapine long-term treatment.
    Racagni G, Bruno F, Bugatti A, Parenti M, Apud JA, Santini V, Carenzi A, Groppetti A, Cattabeni F.
    Adv Biochem Psychopharmacol; 1980 May; 24():45-51. PubMed ID: 7405672
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter.
    Fachinetto R, Villarinho JG, Wagner C, Pereira RP, Avila DS, Burger ME, Calixto JB, Rocha JB, Ferreira J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1478-86. PubMed ID: 17669571
    [Abstract] [Full Text] [Related]

  • 20. Homovanillic acid concentrations in brain, CSF and plasma as indicators of central dopamine function in primates.
    Elsworth JD, Leahy DJ, Roth RH, Redmond DE.
    J Neural Transm; 1987 Oct 01; 68(1-2):51-62. PubMed ID: 3806086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.